Sleep

Telemedicine was indicated to provide complete and appropriate care for addressing pediatric sleep disorders such as insomnia and circadian rhythm disorders, whereas obstructive sleep apnea was better evaluated in office.

Former e-cigarette users were found to be more likely to report sleep deprivation compared with never users, according to study findings.

In addressing sleep-related challenges prior to and influenced by the coronavirus disease 2019 pandemic, researchers outline factors that contribute to optimal sleep hygiene among children and adolescents.

Health workers providing care on the front lines of the coronavirus disease 2019 (COVID-19) pandemic were found to develop more sleep disturbances and have worse quality of sleep compared with non-health care professionals.

In 2 separate articles, researchers review the relationship between obstructive sleep apnea (OSA) and cardiovascular disease, as well as the effects of continuous positive airway pressure treatment on level of physical activity in patients with these comorbid conditions.

Impaired sleep was found to contribute to more emotional reactions by study participants to stressful events the next day, with a comparative indifference to positive events also reported.

Researchers find that 32% of examined contact sport athletes who had developed chronic traumatic encephalopathy experienced sleep symptoms characteristic of rapid eye movement sleep behavior disorder, which only affect an estimated 1% of the general population.

Impaired sleep was associated with a higher rate of future beta amyloid accumulation, a potential catalyst of Alzheimer disease onset, according to study findings.

In findings from a novel global atlas study published today, 19 risk factors were identified to increase risk of developing type 2 diabetes, with insomnia identified as a risk factor for the first time.

For patients with insomnia amid the COVID-19 pandemic, certain nightly habits can promote sleep hygiene; in addition, lemborexant has emerged as a novel indication if drug intervention is needed.

Narcolepsy, along with several other conditions are examined as potential risk factors for coronavirus disease 2019 susceptibility and adverse outcomes.

Data to be presented at SLEEP 2020 showed Eisai Inc's lemborexant (DAYVIGO) had statistically significant long-term efficacy and safety compared with placebo on sleep maintenance and onset in patients with insomnia disorder, said Margaret Moline, PhD.

Increased sleep need, poor sleep quality, and fatigue were found to occur more frequently and longer among patients with concussions, according to study findings.

The prevalence of such sleep disorders as narcolepsy and obstructive sleep apnea increased appreciably from 2013 to 2016. It is unknown whether this is due to increased awareness or increased incidence.

Short-term use of acetazolamide was shown to improve both obstructive sleep apnea (OSA) and central sleep apnea (CSA), with significantly greater reductions in the apnea-hypopnea index observed with higher doses.

Researchers discuss current and prospective pharmacological therapies for treating both excessive daytime sleepiness and cataplexy in patients with narcolepsy, as well as efforts to address narcolepsy stigma.

The impact of impaired sleep, which is more frequent among adolescents, was associated with a greater risk of asthma and allergies among this age group, but association does not equal causation. As a result, these associations warrant greater investigation, as well as the potential effects of social determinants of health such as race and socioeconomic status, said Lakiea Wright, MD, practicing physician at Brigham and Women's Hospital in Boston and the medical director at Thermo Fisher Scientific.

Cognitive behavioral therapy for insomnia delivered via telemedicine was found to be noninferior to in-person delivery in managing severity, with similar improvements in daytime functioning exhibited between the 2 methods, according to study findings.

Amid the coronavirus disease 2019 pandemic in Italy, a significant number of patients with epilepsy reported difficulties managing their condition, especially those who reported greater use of antiseizure medications for chronic therapy and poor sleep quality, according to study findings.

This week, the FDA approved Jazz Pharmaceuticals’ XywavTM (calcium, magnesium, potassium, and sodium oxybates), an oral solution for the treatment of cataplexy or excessive daytime sleepiness in patients 7 years and older with narcolepsy.

Increases in different aspects of snoring, such as frequency and loudness, among patients with obstructive sleep apnea and established cardiovascular disease were associated with greater risks of cerebral but not cardiac events, according to study findings.

Automatic positive airway pressure was found to significantly improve peak oxygen uptake, left ventricular function, and quality of life in patients with comorbid obstructive sleep apnea and heart failure with reduced left ventricular ejection fraction, according to study findings.

Patients with type 2 diabetes who sleep too much (≥ 10 hours) or too little (≤ 5 hours) were found to exhibit a higher mortality rate. Those at a younger age of diabetes onset who reported longer sleep duration were also associated with greater risks of all-cause and cardiovascular mortality, according to study findings published today.

In medical and nursing staff experiencing insomnia while working in Wuhan, China, during the coronavirus disease 2019 epidemic, stress was a notable predictor in those with comorbid sleep apnea–hypopnea syndrome, according to study findings.

Hospitalized patients with chronic obstructive pulmonary disease (COPD) were shown to be at greater risk of obstructive sleep apnea (OSA) and insomnia than those without COPD, with worse outcomes for in-hospital sleep quality and quantity also observed, according to study findings.